Institutional Research Information Service
UCL Logo
Please report any queries concerning the funding data grouped in the sections named "Externally Awarded" or "Internally Disbursed" (shown on the profile page) to your Research Finance Administrator. Your can find your Research Finance Administrator at https://www.ucl.ac.uk/finance/research/rs-contacts.php by entering your department
Please report any queries concerning the student data shown on the profile page to:

Email: portico-services@ucl.ac.uk

Help Desk: http://www.ucl.ac.uk/ras/portico/helpdesk
 More search options
Prof David Werring
Stroke Research Centre
UCL Queen Square Institute of Neurology
Prof David Werring profile picture
  • Professor of Clinical Neurology
  • Brain Repair & Rehabilitation
  • UCL Queen Square Institute of Neurology
  • Faculty of Brain Sciences

David is Professor of Clinical Neurology and Honorary Consultant Neurologist at the Stroke Research Centre, UCL Institute of Neurology, Queen Square, and the National Hospital for Neurology and Neurosurgery (NHNN), University College Hospitals (UCH) NHS Foundation Trust. He trained in medicine at Guy's hospital and in neurology at Kings College Hospital, St Thomas' hospital and the National hospital, Queen Square.  Professor Werring contributes to delivering hyperacute and acute stroke care, and runs a specialist clinical service and research program in intracerebral haemorrhage and cerebral small vessel disease. He is Head of the Research Department of Brain Repair and Rehabilitation at the Institute of Neurology, Chair of the Association of British Neurologists Stroke Advisory Group, Stroke Specialty Lead for the NIHR North Thames Clinical Research Network, Secretary of the British Association of Stroke Physicians, Expert Advisor to the NICE centre for guidelines, and on the Editorial Boards of the European Journal of Neurology, European Stroke Journal, and Practical Neurology. David is also Chair-Elect for the UK Stroke Forum, the largest multidisciplinary event for stroke care professionals in the UK. 


Research Groups
Research Themes
Research Summary

As a clinical academic I divide my time equally between clinical stroke care (at University College Hospital and The National Hospital for Neurology and Neurosurgery, Queen Square) and academic commitments at the Stroke Research Centre, UCL Institute of Neurology. My major research interest is in the clinical an pathophysiological implications of cerebral small vessel disease (the commonest known brain disorder). My focus is on intracranial (including intracerebral) haemorrhage, which is the most devastating type of stroke. I have expertise in observational studies and neuroimaging including magnetic resonance imaging (MRI). I lead a research programme including observational, genetic and neuroimaging studies of subarachnoid haemorrhage and intracerebral haemorrhage, with particular expertise in cerebral amyloid angiopathy. I was Chief Investigator for the Clinical Relevance of Microbleeds in Stroke (CROMIS-2) study: www.ucl.ac.uk/cromis-2 and the Geneticand Observational Subarachnoid Haemorrhage (GOSH) Study.  I was Chief investigator for the Biomarkers in Cerebral Amyloid Angiopathy (BOCAA) at UCL. I was UK Chief investigator for a therapeutic trial of the monoclonal antibody Ponezumab in Cerebral Amyloid Angiopathy. In collaboration with Prof Peter Rothwell (Oxford) I am Co-Chief Investigator for a randomised controlled trial of blood pressure lowering after intracerebral haemorrhage (Prevention Of Hypertensive Injury to the Brain - Intracerebral haemorrhage: PROHIBIT-ICH) funded by the Stroke Association.  I am Chief Investigator of the BHF-funded OPTIMAS (Optimal Timing of Anticoagulation in Stroke) trial, currently running at over 60 hospitals in the UK. I am lead for the Microbleeds International Collaborative Network (MICON). I am Principal Investigator for numerous collaborative National Institute of Health Research (NIHR)-funded stroke research studies and am Speciality Lead for Stroke in the NIHR Clinical Research Network: North Thames.  I am a member of Trial Steering Committees for NIHR multi-centre studies including TICH-3(Tranexamic Acid in Intracerebral Haemorrhage), R4VaD (Risks, Rates and Routes to Reduce Vascular Dementia), LACI-2 (Lacunar Intervention) and Remote Ischaemic Conditioning After Stroke (RECAST-3), Tenecteplase in Wake-up Ischaemic Stroke Trial (TWIST). 

Teaching Summary

Prof Werring supervises Stroke Medicine clinical postgraduate trainees, and teaches widely on UCL MSc. courses. He teaches undergraduates at UCL and postgraduates nationally and internationally.

Prof Werring supervises PhD and postdoctoral students and is pleased to receive enquiries from potential students. 

Prof Werring is Course Director and teacher on the faculty of the UCL MSc./ MRes. / PG Cert. in Stroke Medicine (http://www.ucl.ac.uk/ion/education/courses/strokemedicine).

Academic Background
2000   Doctor of Philosophy University College London
1992   Bachelor of Medicine/Bachelor of Surgery University of London
1989   Bachelor of Science University of London
Some IRIS profile information is sourced from HR data as explained in our FAQ. Please report any queries concerning HR data shown on this page to hr-services@ucl.ac.uk.
University College London - Gower Street - London - WC1E 6BT Tel:+44 (0)20 7679 2000

© UCL 1999–2011

Search by